Azimuth Capital Investment Management LLC
Source: SEC Form 13F · as of Mar 2026Azimuth Capital Investment Management LLC holds 22 biotech & pharma companies tracked by BioSniper, totaling $231.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
22
Total value held
$231.0M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 66,598 | $61.3M |
| ABBVAbbVie Inc. | 101,872 | $22.2M |
| JNJJOHNSON & JOHNSON | 88,108 | $21.5M |
| IDXXIDEXX LABORATORIES INC /DE | 30,214 | $17.0M |
| NBIXNEUROCRINE BIOSCIENCES INC | 121,704 | $16.0M |
| MRKMerck & Co., Inc. | 132,533 | $15.9M |
| GILDGILEAD SCIENCES, INC. | 96,471 | $13.4M |
| AZNASTRAZENECA PLC | 58,545 | $11.5M |
| PFEPFIZER INC | 401,847 | $11.3M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 18,656 | $8.3M |
| BMYBRISTOL MYERS SQUIBB CO | 120,157 | $7.3M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 25,743 | $7.0M |
| AMGNAMGEN INC | 18,265 | $6.4M |
| ABTABBOTT LABORATORIES | 61,138 | $6.3M |
| CAHCardinal Health Inc. | 8,628 | $1.8M |
| NEOGNEOGEN CORP | 90,200 | $838K |
| GMEDGlobus Medical Inc. | 9,628 | $830K |
| ZTSZoetis Inc. | 6,848 | $810K |
| PMPhilip Morris International Inc | 3,625 | $599K |
| GMOptec International, Inc. | 3,870 | $288K |
| NVSNovartis AG | 1,598 | $244K |
| ESPREsperion Therapeutics, Inc. | 22,000 | $60K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.